Clinical trial
Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary…
NCT00366093 · Sumitomo Pharma America, Inc., Industry · Completed
Key facts
| NCT number | NCT00366093 |
|---|---|
| Title | Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause |
| Official title | The Efficacy of Eszopiclone 3 mg Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause or Menopause |
| Lead sponsor | Sumitomo Pharma America, Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Insomnia |
| Intervention type | Drug |
| Interventions | Eszopiclone, Placebo |
| Enrollment | 410 |
| Start date | Feb 1, 2004 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Aug 18, 2006 |
| Last update posted | Feb 22, 2012 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: